The Latest in GI Oncology

Colorectal polyps and cancer – when to refer to genetics

February 1, 2020

GI Oncology

Dual immunotherapy goes the distance in MSI-H colorectal cancer

January 29, 2020

GI Oncology

Blood test may advance diagnosis of GI cancers

January 24, 2020

GI Oncology

Three or more nonadvanced adenomas no longer spell increased CRC risk

January 22, 2020

Eradicating H. pylori may cut risk of gastric cancer

January 11, 2020

GI Oncology

FDA approves avapritinib for adults with GIST with PDGFRA mutation

January 10, 2020

GI Oncology

Unique T cell populations pinpointed in hepatocellular carcinoma tissue

January 9, 2020

GI Oncology

ctDNA outmatches CEA for detection of colorectal cancer recurrence

January 9, 2020

GI Oncology

AGA publishes clinical practice guidelines for gastric intestinal metaplasia

January 3, 2020

GI Oncology

Loss of pancreatic E-cadherin contributes to carcinogenesis

December 3, 2019

Wide-area transepithelial sampling may be best method for detecting esophageal intestinal metaplasia

November 26, 2019

Over half of NASH patients have improvement in liver fibrosis after bariatric surgery

November 13, 2019

Direct-acting antiviral treatment linked to lower mortality in patients with HCC history

November 12, 2019

Postcolonoscopy colorectal cancers had unique features

November 11, 2019

GI Oncology

Threshold for positivity affects FIT sensitivity for detecting CRC, advanced adenomas

November 5, 2019